Funder
National Heart Lung and Blood Institute
Cystic Fibrosis Foundation
Subject
Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health
Reference5 articles.
1. CFTR modulator therapy in patients with cystic fibrosis and an organ transplant;Mitchell;Paediat. Respirat. rev.,2018
2. Administration FaD. Drug Approval Package: trikafta Food and Drug Administration [Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/212273Orig1s000MultidisciplineR.pdf.
3. Pulmonary function between 6 and 18 years of age;Wang;Pediatr Pulmonol,1993
4. Clinical drug-drug interaction assessment of ivacaftor as a potential inhibitor of cytochrome P450 and P-glycoprotein;Robertson;J. Clinical Pharmacol.,2015
5. Lumacaftor/ivacaftor initiation in two liver transplantation patients under tacrolimus and antifungal azoles;Chouchane;Clin. Case Rep.,2019
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献